サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：バイオバンキング市場レポート：2030年までの動向、予測、競合分析
市場調査レポート
商品コード
1356780

バイオバンキング市場レポート：2030年までの動向、予測、競合分析

Biobanking Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

バイオバンキング市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年10月03日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

バイオバンキングの動向と予測

世界のバイオバンキング市場は、2024年から2030年までのCAGRが10.5%で、2030年までに推定61億米ドルに達すると予想されています。この市場の主な促進要因は、遺伝子検査と精密医療に対する需要の高まり、新生児の臍帯血幹細胞保存の人気の高まり、バーチャル・バイオバンク・ソフトウェアの出現です。世界のバイオバンキング市場の将来は、製薬・バイオテクノロジー企業やCRO、学術・研究機関、病院市場におけるビジネスチャンスで有望視されています。

バイオバンキング市場の洞察

Lucintelは、予測期間中、機器が最も高い成長を遂げると予測しています。

アジア太平洋は予測期間中に最も高い成長が見込まれます。

本レポートでは、以下の11の主要な質問に回答しています：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界のバイオバンキング市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界のバイオバンキング市場動向（2018-2023）と予測（2024-2030）
  • サンプルタイプ別の世界のバイオバンキング市場
    • 血液製剤
    • ヒト組織
    • 細胞株
    • 核酸
    • 体液
    • し尿製品
  • 製品およびサービス別の世界のバイオバンキング市場
    • 装置
    • 消耗品
    • サービス
    • ソフトウェア
  • アプリケーション別の世界のバイオバンキング市場
    • 再生医療
    • ライフサイエンス調査
    • 臨床調査
  • 最終用途別の世界のバイオバンキング市場
    • 製薬およびバイオテクノロジー企業およびCRO
    • 学術調査機関
    • 病院

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界のバイオバンキング市場
  • 北米のバイオバンキング市場
  • 欧州バイオバンキング市場
  • アジア太平洋バイオバンキング市場
  • その他地域バイオバンキング市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • サンプルタイプ別の世界のバイオバンキング市場の成長機会
    • 製品とサービス別の世界のバイオバンキング市場の成長機会
    • アプリケーション別の世界のバイオバンキング市場の成長機会
    • 最終用途別の世界のバイオバンキング市場の成長機会
    • 地域別の世界のバイオバンキング市場の成長機会
  • 世界のバイオバンキング市場における新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界のバイオバンキング市場の能力拡大
    • 世界のバイオバンキング市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Thermo Fisher Scientific
  • PHC Holdings
  • Becton
  • Dickinson and Company
  • QIAGEN N.V.
  • Merck KGaA
  • Avantor
  • Cryoport
  • Tecan Trading
  • Azenta
目次

Biobanking Trends and Forecast

The future of the global biobanking market looks promising with opportunities in the therapeutics, drug discovery & clinical research, clinical diagnostics, and other markets. The global biobanking market is expected to reach an estimated $xxx billion by 2030 with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are significant capital allocation to the research and development of cutting-edge therapies, including regenerative medicine, personalized medicine and in-depth studies on cancer genomics and high incidence of chronic diseases.

A more than 150-page report is developed to help in your business decisions.

Biobanking by Segment

The study includes a forecast for the global biobanking by product & service, sample type, application, end use industry, and region.

Biobanking Market by Product & Service [Shipment Analysis by Value from 2018 to 2030]:

  • Equipment
  • Consumables
  • Software
  • Services

Biobanking Market by Sample Type [Shipment Analysis by Value from 2018 to 2030]:

  • Blood
  • Tissue
  • Nucleic Acids
  • Cell Lines

Biobanking Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Therapeutics
  • Drug Discovery & Clinical Research
  • Clinical Diagnostics
  • Other Applications

Biobanking Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Pharmaceutical & Biotechnology Companies and Cros
  • Academic & Research Institutes
  • Hospitals

Biobanking Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Biobanking Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies biobanking companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biobanking companies profiled in this report include-

  • Thermo Fisher Scientific
  • PHC Holdings
  • Becton
  • Dickinson and Company
  • Qiagen
  • Greiner Holding
  • Bay Biosciences

Biobanking Market Insights

Lucintel forecasts that equipment is expected to witness highest growth over the forecast period due to due to need of wide range of specialized equipments and products essential for the processing, analysis, storage, and transport of biological samples.

Within this market, therapeutics will remain the largest segment due to the growing demand for advanced therapies for the treatment of chronic diseases.

North America is expected to witness highest growth over the forecast perioddue to growing government efforts, including funding and the advancement of the biobanks market in the united states.

Features of the Global Biobanking Market

Market Size Estimates: Biobanking market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Biobanking market size by various segments, such as by product & service, sample type , application, end use industry, and region in terms of ($B).

Regional Analysis: Biobanking market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product & service, sample types , applications, end use industries, and regions for the biobanking market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biobanking market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the biobanking market size?

Answer: The global biobanking market is expected to reach an estimated $xxx billion by 2030.

Q.2 What is the growth forecast for biobanking market?

Answer: The global biobanking market is expected to grow with a CAGR of 7.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the biobanking market?

Answer: The major drivers for this market are significant capital allocation to the research and development of cutting-edge therapies, including regenerative medicine, personalized medicine and in-depth studies on cancer genomics and high incidence of cronic diseases.

Q4. What are the major segments for biobanking market?

Answer: The future of the biobanking market looks promising with opportunities in the therapeutics, drug discovery & clinical research, clinical diagnostics, and other markets.

Q5. Who are the key biobanking market companies?

Answer: Some of the key biobanking companies are as follows:

  • PHC Holdings
  • Becton
  • Dickinson and Company
  • Qiagen
  • Greiner Holding
  • Bay Biosciences
  • Bay Biosciences

Q6. Which biobanking market segment will be the largest in future?

Answer: Lucintel forecasts that equipment is expected to witness highest growth over the forecast period due to due to need of wide range of specialized equipments and products essential for the processing, analysis, storage, and transport of biological samples.

Q7. In biobanking market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast perioddue to growing government efforts, including funding and the advancement of the biobanks market in the united states.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the biobanking market by product & service (equipment, consumables, software, and services), sample type (blood, tissue, nucleic acids, and cell lines), application (therapeutics, drug discovery & clinical research, clinical diagnostics, and other applications), end use industry (pharmaceutical & biotechnology companies and cros, academic & research institutes, and hospitals), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Biobanking Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Biobanking Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Biobanking Market by Product & Service
    • 3.3.1: Equipment
    • 3.3.2: Consumables
    • 3.3.3: Software
    • 3.3.4: Services
  • 3.4: Global Biobanking Market by Sample Type
    • 3.4.1: Blood
    • 3.4.2: Tissue
    • 3.4.3: Nucleic Acids
    • 3.4.4: Cell lines
  • 3.5: Global Biobanking Market by Application
    • 3.5.1: Therapeutics
    • 3.5.2: Drug Discovery & Clinical Research
    • 3.5.3: Clinical Diagnostics
    • 3.5.4: Other Applications
  • 3.6: Global Biobanking Market by End Use Industry
    • 3.6.1: Pharmaceutical & Biotechnology Companies and CROs
    • 3.6.2: Academic & Research Institutes
    • 3.6.3: Hospitals

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Biobanking Market by Region
  • 4.2: North American Biobanking Market
    • 4.2.2: North American Biobanking Market by Application: Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics, and Other Applications
  • 4.3: European Biobanking Market
    • 4.3.1: European Biobanking Market by Product & Service: Equipment, Consumables, Software, and Services
    • 4.3.2: European Biobanking Market by Application: Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics, and Other Applications
  • 4.4: APAC Biobanking Market
    • 4.4.1: APAC Biobanking Market by Product & Service: Equipment, Consumables, Software, and Services
    • 4.4.2: APAC Biobanking Market by Application: Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics, and Other Applications
  • 4.5: ROW Biobanking Market
    • 4.5.1: ROW Biobanking Market by Product & Service: Equipment, Consumables, Software, and Services
    • 4.5.2: ROW Biobanking Market by Application: Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics, and Other Applications

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Biobanking Market by Product & Service
    • 6.1.2: Growth Opportunities for the Global Biobanking Market by Sample Type
    • 6.1.3: Growth Opportunities for the Global Biobanking Market by Application
    • 6.1.4: Growth Opportunities for the Global Biobanking Market by End Use Industry
    • 6.1.5: Growth Opportunities for the Global Biobanking Market by Region
  • 6.2: Emerging Trends in the Global Biobanking Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Biobanking Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biobanking Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: PHC Holdings
  • 7.3: Becton
  • 7.4: Dickinson and Company
  • 7.5: QIAGEN
  • 7.6: Greiner Holding
  • 7.7: Bay Biosciences